clofarabine has been researched along with Nevoxanthoendothelioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ainsworth, J; Mifsud, M; Picton, S | 1 |
| Allen, CE; Beaupin, LK; Bilgi, M; Coulter, D; Garrington, T; Hicks, MJ; Jones, J; McCavit, TL; McClain, KL; Moore, C; Rivera-Ortegón, F; Shaffer, L; Simko, SJ; Stork, L; Tran, HD; Turcotte, L; Welsh, EC | 1 |
2 other study(ies) available for clofarabine and Nevoxanthoendothelioma
| Article | Year |
|---|---|
Bilateral retinal involvement in juvenile xanthogranuloma-Successful treatment with clofarabine.
Topics: Child; Clofarabine; Humans; Retina; Skin; Xanthogranuloma, Juvenile | 2021 |
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
Topics: Adenine Nucleotides; Adolescent; Antimetabolites, Antineoplastic; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Female; Histiocytosis, Langerhans-Cell; Histiocytosis, Sinus; Humans; Infant; Male; Recurrence; Salvage Therapy; Xanthogranuloma, Juvenile | 2014 |